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A B S T R A C T
Through the treatment of anaemia in dialysis patients part of the iron ions remain free in the serum which is at the
bacterias disposal for growth and the strengthening of their virulence. The linear relation of the increased serum iron
level and tissue iron stores in the body and the infection incidence in dialysed patients has become more emphasised. The
need of a clearly defined upper threshold of the serum iron concentration limit has been mentioned in scientific journals
intensely, and consequently the demand for more precise professional instructions for anaemia treatment. For the pur-
pose of participating in these professional and scientific discussions, we have observed the relation between the iron over-
load of the organism and complication incidence in 120 of our haemodialysis uremic patients, with special emphasis on
infections. It has been established that the sepses incidence is much higher in patients with a serum ferritin concentra-
tion above 500 mg/L, than in those patients with a ferritin level lower than the mentioned value (c2=7.857, p=0.005). The
incidence of vascular access infection is significantly higher in those patients with a serum ferritin level above 500 mg/L
than in those patients with a ferritin level lower than the mentioned value (c2=23.186, p=0.001). Furthermore, it has
been determined that the incidence of total infection in patients is 3.8 episodes per 100 patients months, which is in accor-
dance to the referral values of other authors. Conclusion – In the analysis of the achieved results, it has been determined
that the infection incidence is significantly higher in dialysed patients with a serum iron level higher than 500 g/L, than
in those patients with lower values.
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Introduction
Anaemia is an accompanying phenomenon in patients
with end-stage renal disease. The loss of blood in dialysed
patients occurs in different ways: by extracorporeal dial-
ysis with accompanying haemolyse, the loss by the rest of
the blood in the dialysis liner and filter, by complications
associated to the vascular access, occult interstitial hae-
morrhaging as well as by the vascular access punction1–3,
and especially by deficient renal production of erythro-
poietins4,5. After implementing haemodialysis in treating
uremic patients, anaemia was corrected by a fresh blood
transfusion6,7 for a long period of time. The annual loss of
blood in some patients, expressed in iron loss, would even
be up to 1500 mg of iron4. Therefore, some of those pa-
tients would receive consecutive transfusions of up to 4 L
of blood1,2,3,8.
Alongside the transfusion application, the correction
of the iron deficit as well as the oral, and in time pa-
renteral application of iron preparations, which is some-
times observed and controlled insufficiently, as well as
erythropoietin9–11, started to be implemented. A low se-
rum ferritin level always indicates iron deficiency. How-
ever, normal and increased levels of serum ferritin, ac-
companied by a low transferrin saturation (<20%) do not
simultaneously indicate that the organism is well sup-
plied by iron, yet it indicates the development a state of
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»functional iron deficiency«12. The erythropoietins appli-
cation demands the introduction of iron into the organ-
ism in order to prevent it from creating unresponsive-
ness to erythropoietin therapy. Providing that the afore-
mentioned therapeutic procedures are insufficiently con-
trolled, a side effect is the increase of the iron concentra-
tion in the serum and tissue iron storage of the organism,
with negative side effects for the organism treated with
chronic haemodialysis.
High therapeutic dosages of iron preparations can
lead to a state in which the intake amount of oral or
parenteral iron surpasses the capacity of transferrin for
binding the iron ions5. In normal circumstances, all iron
ions brought into the organism are bound to transferrin,
and thus become inactive for other systems5,13. Bound in
such a way they also even become unavailable for bac-
teria14,15. However, Lindsay et al.15 established that sta-
phylococcus aureus could be used for the growth and de-
velopment of virility even by iron bound to transferrin.
Iron ions not bound to transferrin are free in the serum
and they become the catalysts for the creation of hy-
droxyl (oxidative) radicals, which disturb the phagocyte
function in addition to the chemotaxis of neutrophile
leukocytes13,16,17, and being exposed to bacteria they sup-
port their growth and virility18. From all the things afore-
mentioned, we can conclude that it is easy to cross the thre-
shold of binding capacity of transferrins for iron ions.
Various discussions throughout medical journals have
taken place concerned with the issue of what the ratio of
iron overload5,8,9,19–21 is in the morbidity and mortality in-
cidence of dialysed patients. In the era of transfusion im-
plementation in treating anaemia of this population of
patients, Hakim et al.22 found a high iron level in 41% of
patients, estimated by the serum ferritn level (>650
mg/L). However, by reducing transfusions and imple-
menting recombinant human erythropoietin into the ana-
emia treatment, as well as the intake of a prescribed
amount of iron preparations, the iron overload incidence
has recently declined, and thus the increased iron level,
as stated by Hoen et al.19, normally ranges between 10%
to 15% of dialysed patients.
Different data concerning the infection frequency in
haemodialysis uremic patients has been published in sci-
entific journals. After we insert the iron overload of the
organism into the equation, determined according to the
serum ferritin level and the frequency of bacterial infec-
tion, we gain an insight into the significance of the iron
overload in dialysed patients8,17,23,24. This refers to the in-
creased bacterial infection25 risk in dialysed patients
with an iron overload. Tielemans et al.7 claim that only
the iron overload in the serum, regardless of the genesis,
increases the growth and virility of the bacteria in vitro
and in vivo. Boleaert et al.8,23 established that the infec-
tion risk is three times greater in patients with a serum
ferritin level above 1000 mg/L than in those patients with
lower values. It was also mentioned that there are mul-
tifactor influences onto the risk of bacterial infection de-
velopment in dialysed patients with an iron overload in
the serum5,19,26.
The intake of iron preparations into the organism of
dialysed patients, especially the sodium ferric gluconat
complex, together with the erythropoietin, decreases the
risk of bacterial infection3,10,11,27. Due to accompanying
effects of the bacterial infection incidence, Michael et
al.3,27 are of the opinion that the routine practice of lib-
eral consumption of iron preparations of this population
should be terminated. On the other hand, the peroral in-
take of iron preparations cannot, in these organisms, re-
tain a safe and stable equilibrium of neither the serum
nor the stored iron27,28. Therefore, in order to maintain
the balance of the serum iron concentration as steady as
possible, the parenteral intake of iron with pronounced
caution on dosages11,26,29,30 is being implemented more
and more. High dosages of therapeutic iron, as conside-
red by Hörl et al.31, develop the conditions for bacterial in-
fections, cardiovascular complications as well as carcinomas.
Treating end-stage renal disease patients with chro-
nic haemodialysis was implemented in the Mostar Uni-
versity Clinical Hospital more than four decades ago. We
have studied the relation between the iron overload of
these organisms and the infection incidence in patients
on a chronic haemodialysis program.
Patients and Methods
The haemodialysis uremic patients with end-stage re-
nal disease have been treated at the Dialysis Ward at the
Mostar University Hospital for four decades. 125 pa-
tients have been chosen for the study and regularly ob-
served throughout 18 months, and the relation between
the serum iron level and the complication incidence, es-
pecially infection, observed. During the research 2 pa-
tients died, whereas three were excluded from the prog-
ramme since they had not been regularly observed. As
the indicator of iron supply level in the organism, the se-
rum ferritin level was chosen, and the serum ferritin
concentration of 500 mg/L was taken as the borderline be-
tween a normal serum level and iron overload of the or-
ganism. The relation between the serum ferritin level
and sepses, as well as the relation between the serum
ferritin level and vascular access infection, were ob-
served separately. The observation purpose was to estab-
lish the aforementioned relations, as well as to determine
the primary point of infection from which the general infe-
ction, in the sense of bacteraemia, was developed. Other
complications, apart from infection, which can put the
vascular access and life of a dialysed patient in danger,
were also taken into the observation process. The serum
ferritin level, erythrocytes level and haemoglobin level in
the blood were also observed.
An arteriovenous fistula for vascular access was set
up in all patients. The patients who, at the time of agree-
ing to take part in the study who did not display any
signs of a local infection or sepses, nor displaying any of
the possible complications that might threaten the vas-
cular access and the patient’s life, were chosen. The pa-
tients who, for any reason, had blood or a blood derivates
transfusion in the last six months, were not taken into
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consideration for the study. Moreover, dialysed patients
younger than 10 years of age were also excluded from the
research.
Descriptive statistics have been used in the basic eval-
uation of the numerical data in order to determine the
mean values, the standard deviation and span. Categori-
cal data has been shown by the frequency of appearance
as well as their proportion, that is, their percentage. In
the statistical analysis we have used the c2-test. The sta-
tistical significance has been regarded on the level of im-
portance p<0.05 that is with 95% of relevance threshold.
For the analysis of the collected data we have used the
application program Statistics version 8.0 whereas the
graphic presentation has been made in Excel.
Results
Table 1 shows the distribution of patients according
to age and sex, whereas Table 2 lists the pathological con-
ditions that caused end-stage renal disease (ESRD). As
can be viewed from Table 2, hypertensive nephrosclero-
sis is the most frequent cause of kidney failure by far,
which represents a distinct difference in relation to other
authors’ reports regarding kidney function failure and
complete anuria. This remains to be processed. Table 3
illustrates the incidence of concomitant diseases, out of
which some can be an independent risk factor in the com-
plications occurrence, especially diabetes.
Table 4 shows the incidence of local infection of vascu-
lar access and the infection of organic system, listed ac-
cording to frequency, which then became the primary
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TABLE 1
DISTRIBUTION OF EXAMINEES ACCORDING TO AGE AND SEX
Age (year) Male Female Total
0–10 – – –
11–20 – 1 1
21–30 3 – 3
31–40 8 6 14
41–50 10 7 17
51–60 23 13 36
61–70 10 7 17
71–80 15 13 28
81–90 – 3 3
91–100 1 – 1
Total 70 50 120
TABLE 2
PATOLOGICAL CONDITION WHICH CAUSED END-STAGE
RENAL DISEASE (ESRD)
Cause of renal insufficiency Total of patients
Hypertensive nephrosclerosis 35
Interstitial nephritis 27
Glomerulonephritis 21
Diabetic nephropathy 12
Chronic pyelonephritis 11
Polycystic kidney 6
Obstructive nephropathy 5
Unknown 3
Total 120
TABLE 3
THE INCIDENCE OF CONCOMITANT DISEASE
Comorbidity Number of patients %
Cardiovascular disease 51 42.5
Diabetes 12 10.0
Carcinoma 5 4.2
Others 2 1.7
TABLE 4
THE ILLUSTRATION OF THE PRIMARY SPOT OF INFECTION AND THE TYPES OF ISOLATED MICROORGANISMS IN IRON OVERLOAD
DIALYSED PATIENTS
Primary spot of infection Number of patients Isolated microorganisms
Number of patients
with microorganisms
%
Vascular access
15 Staphylococcus epidermidis 4 26.6
Streptococcus aureus 6 40.0
Infection of respiratory system
16 Streptococcus pneumoniae 1 6.2
Klebsiella pneumoniae 2 12.4
Infection of urinary system
9 Escherichia coli 3 33.3
Enterococcus species 2 22.2
Infection of skin and soft tissues
4 Streptococcus pyogenes 1 25.0
Streptococcus aureus 2 50.0
Staphylococcus epidermidis 1 25.0
Endocarditis 2 Staphylococcus epidermidis 2 100.0
Others 2 – – –
Total 48 24
point of the bacteraemia occurrence. The patients who
displayed the general symptoms and the laboratory re-
sults confirmed bacteraemia were treated and recorded
as patients with sepses. Table 4 illustrates that out of 120
observed haemodialysis uremic patients, 48 (40.0%) of
them displayed the symptoms of a local and systematic
infection, and from those 48 patients with infection, 40
(83.3%) of them had symptoms and laboratory results
which indicated that it was bacteraemia, hence, the ap-
propriate treatment to the displayed septic condition was
implemented.
Table 5 illustrates maximum, minimum and middle
values, as well as the standard deviation of the observed
variables of the serum level. Table 6 illustrates the distri-
bution of patients according to the serum ferritin level.
In this table it can be seen that 21 (17.5%) had a serum
ferritin concentration above 500 mg/L, and this particular
level was perceived throughout the study as the thresh-
old of iron overload dialysed patients, that is, patients
with a serum ferritin level above this level were consid-
ered, throughout the treatment in progress, as iron over-
load patients. Therefore, in the observed clinical mate-
rial, 17.5% patients had iron overload. It can also be
noticed in Table 6 that 50 (41.67%) of the patients had a
ferritin level below 200 mg/L, which means that they had
a certain level of iron deficiency since this serum ferritin
level is normally perceived as a lower serum value.
Table 7 shows the distribution of patients according
to the erythrocytes number, and Table 8 according to the
haemoglobin level in the blood. From the tables afore-
mentioned, it is evident that 87.5% of the patients had a
blood haemoglobin concentration below 4,0 million, and
79.2% had a haemoglobin level below 4.0 g/L, which
means that former were at a higher and the latter at a
lower level of insufficiency. A point of interest that needs
pointing out, one patients actually displayed an erythro-
cytes value below 2 million/L.
Table 9 shows the complications which endanger vas-
cular access and consequently the life of the patient in
the programme of chronic haemodialysis. 59 patients ex-
hibited one of the listed complications. It can be viewed
that of the 120 patients (100.0%), infection was the most
common complication and it was exhibited in 48 (81.0%)
patients. This number is comprised of the patients with a
local infection of the vascular approach, as well as the pa-
tients with an infection of some of the organ systems,
which then developed into sepses. The table also illus-
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TABLE 5
THE ILLUSTRATION OF MINIMUM, MAXIMUM AND MIDDLE
VALUES, AS WELL AS THE STANDARD DEVIATION OF
MONITORED VARIABLES OF SERUM LEVELS
Variable Min Max X SD
Serum proteins g/L 30.6 85.1 63.46 6.93
Serum albumins g/L 20.2 50.1 36.6 3.8
C-reactive proteins mg/L 0.1 191.8 12.31 21.05
Serum ferritin mg/L 4.43 1119 169.05 206.58
Hemoglobin g/L 59 160 102.61 17.83
Urea prior to dialysis
mmol/L
5.2 44 21.3 5.16
Serum Calcium mmol/L 5.24 13.12 8.94 0.84
TABLE 6
DISTRIBUTION OF EXAMINEES ACCORDING TO SERUM
FERRITIN CONCENTRATION
Serum ferritin
level (mg/L)
Number of
patients
%
<100 31 31.3
99
82.5%
101–200 19 19.2
201–300 28 28.3
301–400 12 12.1
401–500 9 9.1
Iron overload 501–600 5 23.8
21
17.5%
601–700 1 4.8
701–800 2 9.5
801–900 7 33.3
901–1000 6 28.6
Total 120 (100.0%)
TABLE 7
DISTRIBUTION OF EXAMINEES ACCORDING TO THE
ERYTHROCYTES CONCENTRATION IN BLOOD
Erythrocytes
number(106/L)
Number of
patients
%
< 2.0 1 0.83
105
87.5%
2.0–2.5 5 4.17
2.5–3.0 17 14.17
3.0–3.5 49 40.83
3.5–4.0 33 27.50
4.0–4.5 9 7.50
12
12.5%
4.5–5.0 6 5.00
> 5.0 – –
Total 120 100.00
TABLE 8
DISTRIBUTION OF EXAMINEES ACCORDING TO THE
HEMOGLOBIN LEVEL IN BLOOD
Hemoglobin level
in serum (g/L)
Number of
patients
%
<7.0 – –
95
79.2%
7.0–8.0 3 2.50
8.0–9.0 10 8.33
9.0–10.0 42 35.00
10.0–11.0 40 33.33
11.0–12.0 16 13.33
25
20.8%
12.0–13.0 6 5.00
13.0–14.0 3 2.50
Total 120 100.00
trates that 13 (27.08%) patients out of 48 (100.0%) had a
serum ferritin level above 500 mg/L and they were, ac-
cording to the set criteria (500 mg/L) in this study, iron
overloaded. Other possible complications, apart from
thrombosis, were displayed in a statistically insignificant
proportion. It can also been viewed from Table 9 that
there is no significant difference regarding the serum
ferritin level according to the number of patients with
complications (c2=2.532, p=0.11).
Table 10 illustrates the relation between the serum
ferritin level and sepses incidence. It can be seen from
the table that in the group of patients with sepses, 13
(32.5%) out of 40 (100.0%) of them had a serum level
above 500 mg/L and 27 (67.5%) below the mentioned
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TABLE 9
RELATION BETWEEN THE SERUM FERRITIN LEVEL AND COMPLICATION INCIDENCE
Serum ferritin
(mg/L) Infection Thrombosis
»Steal«
syndrome
Monomyelic
neuropathy
Pseudoaneurism
Bleeding
seroma
Total
<100 11 3 – – – 1 15
35
72.9%
101–200 4 3 – – – 1 8
201–300 7 – – – – – 7
301–400 7 1 – – 1 – 9
401–500 6 1 – – – – 7
501–600 3 – – – – – 3
13
27.1%
601–700 1 – – – – – 1
701–800 2 – – – – – 2
801–900 4 – – – – – 4
901–1000 3 – – – – – 3
Total
48
(81.3%)
8
(13.56%)
0
–
0
–
1
(1.69%)
2
(3.39%)
59
(100%)
Serrum ferritin level mg/L Number of patients
with complications
Number of patients
without complication
c2 p
<500 35 53
2.532 0.11
>500 13 8
TABLE 10
THE RELATION BETWEEN THE SERUM FERRITIN LEVEL AND SEPSES
Patients
%
With sepses
Ferritin serum
Level (mg/L)
With sepses Without sepses Total
%
Without sepses
27
67.5%
<100 6 25 31
72%
90.0%
101–200 4 15 19
201–300 6 22 28
301–400 5 7 12
401–500 6 3 9
13
32.5%
501–600 3 2 5
8
10.0%
601–700 1 – 1
701–800 2 – 2
801–900 4 3 7
901–1000 3 3 6
Total 40 80 120 (100.0%)
40
<500 mg/L=27=67.5% 80.0–35.0=45.0 80 <500 mg/L=72=90.0%
>500 mg/L=13=32.5% >500 mg/L=8=10.0%
Serum ferritin
level (mg/L)
Number of patients
with sepses
Number of patients
without sepses
c2 p
<500 27 72
7.857 0.005
>500 13 8
level. The difference between these two determined lev-
els is 35.0%, and it expresses the infection incidence ratio
in relation to the serum ferritin level within the group of
patients with sepses.
Among patients without sepses, 8 (10.0%) of them out
of 80 (100.0%) had a serum ferritin level above 500 mg/L,
and 72 (90.0%) of them below this value. The difference
between these two determined values is 80.0% expressed
in percentages, and it expresses the infection incidence
ratio in relation to the serum ferritin level within the
group of patients without sepses.
If the two values determined in each group of patients
are compared, that is, 80.0% and 35.0%, the difference is
50.0% and it is statistically significant (c2=7.857, p=0.005).
This difference in particular addresses the level of associ-
ation between the sepses incidence and iron overload
(500 mg/L) in haemodialysis uremic patients. The infec-
tion incidence, if expressed in percentages, is signifi-
cantly higher among the observed patients with a serum
ferritin level above 500 mg/L than among those patients
with lower values.
The relation between the vascular access local infec-
tion and the serum ferritin concentration is illustrated in
Table 11. It is evident from that table that 15 (12.5%) out
of 120 (100.0%) patients displayed a local infection of the
vascular access. From those 15 (100.0%) patients with an
infection of the vascular access, 10 (66.66%) of them had
a serum ferritin level above 500 mg/L, and 5 (33.33%) of
them below this value. The difference between these two
determined values, expressed in percentage is 33.33%,
and it indicates the relation between the patients with a
vascular access infection and the iron overload ratio, that
is, the infection incidence and iron overload relation.
Among the patients without a vascular access local in-
fection, 12 (11.42%) out of 105 (100.0%) of them had a se-
rum ferritin level above 500 mg/L and 93 (88.57%) of
them below this value. The difference between these two
values expressed in percentage is 77.15%, and states the
iron overload ratio among the patients without local in-
fection of vascular access.
If two the values determined in both formed groups of
patients are compared, that is, 77.15% and 33.33%, the
difference is 43.82% which is statistically significant
(c2=23.186, p=0.001). This difference addresses the as-
sociation level between the vascular access infection inci-
dence and iron overload (above 500 mg/L) in haemodialy-
sis uremic patients. The incidence of vascular access local
infections expressed in percentages is significantly hi-
gher in those with a serum ferritin level above 500 mg/L,
than in those with a serum concentration below this
value.
Discussion
High therapeutic dosages of iron preparations can
lead to the state where the amount of orally or paren-
terally intake or iron surpasses the capacity of the trans-
ferrin to bind iron ions5. Under normal circumstances,
all the ions brought into the organism are bound to
transferrin, and thus become inactive for other systems5,13.
Bound in such a way, they are not accessible even to
bacteria14. Iron ions not bound to transferrin are free in
the serum, and they become catalysts for the develop-
ment of hydrophilic (oxidative) radicals, which disturb
the phagocytes function and the chemotaxis of polymor-
phonuclear granulocytes13,16,17, and they are also at the
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TABLE 11
THE RELATION BETWEEN THE SERUM FERRITIN LEVEL AND VASCULAR ACCESS INFECTION INCIDENCE
Patients
%
With infection
Serum ferritin
level (mg/L)
With vascular approach
infection
Without vascular
approach infection
Total
%
Without infection
5
33.33%
<100 – 31 31
93
88.57%
101–200 – 19 19
201–300 1 27 28
301–400 3 9 12
401–500 1 7 9
13
66.67%
501–600 2 3 5
12
11.42%
601–700 1 – 1
701–800 2 – 2
801–900 4 4 8
901–1000 1 5 6
Total 15 (13.25) 105 (86.75) 120 (100.0%)
Serum ferritin
level (mg/L)
With vascular
approach infection
Without vascular
approach infection
c2 p
<500 5 93 23.86 <0.001
>500 10 12
bacteria’s disposal supporting their growth and viru-
lentia18. It can be concluded that the threshold of binding
capacity of the transferrin for iron ions can be easily
crossed.
Professional reports mention different data regarding
the frequency of infection in haemodialysis uremic pa-
tients. When the iron overload determined by the serum
ferritin concentration is compared to the frequency of
bacterial infection, we gain an insight into the signifi-
cance of an iron overload in dialysed patients8,17,23,24.
There is an increased bacteria infection risk in dialysed
patients with iron overload25. Tielemans et al.7 claim
that just a serum iron increase, regardless of the genesis,
strengthens the growth and bacteria virility in vitro and
in vivo. Boelaert et al.8,23 determined that the infection
risk is up to three times higher in patients with a serum
ferritin level above 1000 mg/L, than in those patients
with lower values. It has also been mentioned that there
are numerous factors influencing the risk of developing
bacteria infections in dialysed patients with an iron over-
load in the serum5,19,26.
The intake of iron preparations into the organism of
dialysed patients, especially the sodium ferric gluconate
complex, together with erythropoietin, reduces the bac-
teria infection risk3,10,27. Due to the accompanying effects
of the bacterial infection incidence, Michael et al.3 are of
the belief that the routine practise of a too liberal intake
of iron preparations into the organism of this population
should be abolished. On the other hand, the oral intake
of iron preparations cannot in such organisms maintain
a secure balance of stored iron27,28. Therefore, in order to
maintain the balance of iron concentration in the serum
as far as possible, a parenteral intake is being applied
more frequently with a cautious dosage26,29,30. Hörl et
al.31 consider that high doses of therapeutic iron develop
various conditions, from an inclination to bacterial infec-
tion, to cardiovascular complications to carcinomas.
There have been numerous discussions held through
medical journals regarding: 1. How big the incidence of
iron overload is in dialysed patients, 2. What the ratio of
iron overload of the organism is in the incidence of mor-
bidity and mortality of this population of patients, 3.
What the upper physiological threshold of the serum
ferritin level is, 4. What is the most appropriate and the
most effective way of applying iron preparations in the
anaemia treatment5,26,27,32 of such patients. It is widely
accepted that the criteria for the overload of the serum
ferritin level is above 500 mg/L9,11,12,19,32. In various stud-
ies, data regarding the ferritin level in the serum has
been mentioned, in other words, regarding the iron over-
load of this population of patients and the incidence is
generally ranging between 10.0% and 15.0%. Patruta et
al.12, as well as Kaufman et al.33 determined that in more
than 10% of their patients, the serum ferritin level was
above 650 mg/L, and the transferrin saturation below
20%, Boelaert al.23 determined the aforementioned value
in 14.3% of their patients, whereas Tielemansa et al.7 as
well as Rotellara et al.34 findings also range within these
limits.
In addition, scientific reports mention various data
regarding the frequency of infection in haemodialysis
uremic patients. The infection incidence in these pa-
tients varies in different medical surroundings, thus, re-
ports mention the incidence to range from 12.0% to
35.0%9. In recent times, the incidence is expressed by the
number of infection episodes throughout 100 patients’
months9,19,21. As a result, the infection incidence in the
materials of Tokarsa et al.21 was 2.2 episodes per 100 pa-
tients months in one analysis, and 3.521 in the other re-
port, whereas Hoen et al.19 had a lower incidence, which
was 0.93, and in Kessler et al.9 it was 2.4. According to
the findings of Tokarsa et al.21, in a third of the patients
with bacterial infection, the infection’s point of entrance
was the vascular access, and according to Kessleru et
al.11, in half of them. Albers35, on the other hand, indi-
cates that infections constitute 20% of all vascular access
complications, and Butterly and Schwab36 had the same
finding. It has been mentioned that infection37,38 is the
cause of death in 12% to 38% of this population of pa-
tients. Himmelfarb and Hakim39 conducted a study sum-
marising the numerous published reports, from which it
was evident that the infection, as referred to in the re-
ports in case, was the cause of death in the range of
13.1% and 35.7% of deceased dialysed patients.
The state of decreased bacterial infection risk3,27 is de-
veloped by a controlled intake of iron preparations into
the organism of dialysed patients. Due to accompanying
effects of the bacterial infection incidence, Michael et al.3
are of the belief that the routine practise of a too liberal
intake of iron preparations into the organism of this pop-
ulation should be abolished. On the other hand, the
peroral intake of iron preparations cannot be maintained
in such organisms, as neither tissue storage nor the se-
rum secure a balance in the iron concentration27,40. The-
refore, the parenteral intake has been applied with an in-
creasingly more cautious dosage11,26,29,30. The intake of
high doses of therapeutic iron into the organism of dialy-
sed patients, as considered by Hörl et al.31, develops con-
ditions, apart from an inclination to bacterial infection,
to cardiovascular complications as well as carcinomas.
Contrary to this, Hoen et al.19 consider that after the in-
troduction of erythropoietin therapy, the iron overload of
dialysed patients does not represent a risk factor, whe-
reas Powe et al.20 claim that in spite of the knowledge
gained regarding the pathophysiological processes, the
septicaemia risk factors have not been marked suffi-
ciently yet.
Furthermore, there is no consent regarding the crite-
ria for establishing and treating of iron deficiency in the
serum and tissue storage11,41–43 nor concerning the man-
ner of iron preparations intake26 into the organism26, and
there is no uniformity regarding the views on the upper
differentiation level between the normal and the in-
creased serum ferritin concentration11,32 nor the optimal
level of haemoglobin concentration44–46. Therefore, Fish-
bane32,47, Auerbach et al.48, Madore et al.49 as well as Lee
et al.50 consider that these problems have not yet been
studied or discussed sufficiently, neither in professional
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literature adequately accentuated, hence, according to
them, the aforementioned subject matter should be re-
searched and discussed in greater depth and consequen-
tly, apart from all other things mentioned, to reach a de-
cision regarding the upper limit of serum ferritin concen-
tration without iron overload risk. In the same token,
Kalantar-Zadeh et al.51, as well as Katoditrou et al.52 be-
lieve that these are professional problems which primar-
ily demand scientific and professional analysis, and then
agree on the consensus, as each and every patient should
be exposed to the least risk regarding the inadequate ap-
plication of iron preparations during anaemia treatment,
and subsequently from the possibility of developing an
iron overload.
The aforementioned view is especially emphasised in
an analysis and recommendation of the USA NKF K/
DOQI, 200653, which then influenced our research in the
field of the issue addressed above. We are putting for-
ward our results for the purpose of scientifically process-
ing and interpreting them. We have conducted a research
regarding the iron overload of dialysed patients and the
relation between this overload and infection incidence. It
is apparent that the establishing of iron deficiency, cor-
rection of such an insufficiency, the possibility of a con-
secutive iron overload with side effects and dangerous
consequences, has not been either completely scientifi-
cally analysed or has a consensus been achieved regard-
ing the issue, as it has been already pointed out. Every
research regarding the subject matter serves as an addi-
tion to the maturity in realising the necessity of the over-
all scientific analysis of the issue, since numerous publi-
cations publish and instigate various debates, put for-
ward different approaches and individual assessments
regarding the matter, which do not result in a consensus
of the vital propositions concerning many issues outli-
ned32,41,42,48,52,54–56.
The results of our research contribute to the scientific
approach in processing the issue with the necessity of
bringing clear and practical instructions as well as sug-
gestions regarding the possible reduction of complica-
tions, and consequently to the reduction of the morbidity
and mortality of haemodialysis uremic patients. In the
research conducted, the 500-mg/L threshold of the serum
ferritin level as a differentiation level between the pre-
supposed physiological and non-physiological level of the
iron supply of the dialysed patients was determined. The
research results of the relation between these two values
and the complication incidence, especially infection, ac-
hieved by this study, provide scientific confirmation con-
cerning the association of the two observed parameters,
that is, an iron overload of the organism and the infec-
tion incidence. By analysing and observation the process
of 120 haemodialysis uremic patients throughout a pe-
riod of 18 months, the achieved research results can be
summarised as follows:
1. 41. 67%of the patients had an iron deficiency,
2. 17. 5% of the patients had an iron overload, that is, a
serum ferritin level above 500 mg/L,
3. 40. 0% of the patients had at least one infection epi-
sode, and 33% of them had at least one septic infec-
tion episode,
4. 12.5% of the patients had a local infection of the vas-
cular access, and in 31,13% of the cases, the entry
point of the infection in the organism was the vascu-
lar access,
5. the sepses incidence is significantly higher in the pa-
tients with a serum ferritin level above 500 mg/L, than
in those patients with a lower serum ferritin level
than the mentioned value (c2=7.857, p=0.005),
6. the incidence of local infection of the vascular access
is significantly higher in the patients with a serum
ferritin level above 500 mg/L, than in those patients
with a lower serum ferritin level than the stated value
(c2=23.186, p=0.001),
7. the overall infection incidence is 3.8 on 100 patients
months.
The illustrated results indicate that an iron overload
represents an independent risk factor in the develop-
ment of conditions for increasing risk of infection. More-
over, an iron overload is seen as a »modifiable factor«
which can be influenced, and in this way it may reduce
the possibility of developing a local infection of the vascu-
lar access and sepses in the organism of haemodialysis
uremic patients. As it has already been mentioned, the
morbidity and mortality of this population of patients
can be decreased in such a way. The research findings of
the relation between infection as a complication and an
iron overload of the observed patients’ organism, shows a
positive correlation between these two observed vari-
ables. Since infection is one of the most influential fac-
tors of morbidity and mortality of dialysed uremic pa-
tients, the decreasing of morbidity and mortality of this
population of patients can be influenced by a meaningful
organised observation process, as well as an appropri-
ately chosen therapeutic approach. It is to be expected
that the results of this research will contribute to a more
studious scientific approach to this issue, which would
then, subsequently, represent a scientific and profes-
sional addition to this study.
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ETIOLO[KI ODNOS SERUMSKE RAZINE @ELJEZA I INCIDENCIJE INFEKCIJE U BOLESNIKA
LIJE^ENIH KRONI^NOM HEMODIJALIZOM
S A @ E T A K
Tijekom lije~enja anemije u dijaliziranih bolesnika dio jona `eljeza ostaje u serumu slobodan tako da je na ras-
polaganju bakterijama za rast i ja~anje njihove virulencije. Sve se vi{e ukazuje u dijaliziranih bolesnika na linearni
odnos povi{ene razine `eljeza u serumu i tkivnim depoima s jedne i incidencije upale s druge strane. U stru~nom se
tisku sve glasnije ukazuje na potrebu jasnog odre|ivanja gornjeg praga limita serumske koncentracije `eljeza, a dos-
ljedno tome i na odre|ivanje preciznijih stru~nih uputa za lije~enje anemije. U nakani da se uklju~imo u te stru~ne i
znanstvene rasprave promatrali smo u 120 na{ih bolesnika lije~enih kroni~nom hemodijalizom odnos optere}enosti
organizma `eljezom i incidencije komplikacija, a posebno infekcije. Utvr|eno je da je incidencija sepse zna~ajno vi{a u
ispitanika sa serumskom razinom feritina iznad 500 mg/L, nego u onih s razinom feritina ni`om od navedene vrijednosti
(c2=7,857, p=0,005). Incidencija infekcije vaskularnog pristupa isto je tako zna~ajno vi{a u ispitanika sa serumskom
razinom feritina iznad 500 mg/L, nego u onih s razinom feritina ni`om od navedene vrijednosti (c2=23,186, p=0,001).
Incidencija sveukupne infekcije u svih ispitanika iznosi 3,8 epizoda na 100 bolesnikovih mjeseci i kre}e se unutar refe-
riranih vrijednosti drugih autora. Zaklju~ak – Ras~lambom postignutih rezultata utvr|eno je da je incidencija infekcije
zna~ajno ve}a u dijaliziranih bolesnika sa serumskom razinom feritina vi{om od 500 mg/L, nego u onih s ni`im vrijed-
nostima.
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